Envarsus XR (Page 9 of 9)
PRINCIPAL DISPLAY PANEL — Envarsus 0.75 mg 30 Count Carton Label
NDC 68992-3075-3
Envarsus XR®
(tacrolimus
extended-release tablets)
0.75 mg
ONCE-DAILY
Swallow tablet whole.
Do not chew, divide,
or crush tablet.
Dosage: See Package Insert
for dosage information.
Always dispense with a Medication Guide
For oral use only
Veloxis PHARMACEUTICALS
30 Tablets
PRINCIPAL DISPLAY PANEL — Envarsus 0.75 mg 30 Count Bottle Label
NDC 68992-3075-3
Envarsus XR®
(tacrolimus extended-release tablets)
0.75 mg
ONCE-DAILY
Always Dispense With a Medication Guide
Swallow tablet whole.
Do not chew, divide, or crush tablet.
30 Tablets Rx only
Veloxis PHARMACEUTICALS
PRINCIPAL DISPLAY PANEL — Envarsus 0.75 mg 100 Count Carton Label
NDC 68992-3075-1
Envarsus XR®
(tacrolimus
extended-release tablets)
0.75 mg
ONCE-DAILY
Swallow tablet whole.
Do not chew, divide,
or crush tablet.
Dosage: See Package Insert
for dosage information.
Always dispense with a Medication Guide
For oral use only
Veloxis PHARMACEUTICALS
100 Tablets
PRINCIPAL DISPLAY PANEL — Envarsus 0.75 mg 100 Count Bottle Label
NDC 68992-3075-1
Envarsus XR®
(tacrolimus extended-release tablets)
0.75 mg
ONCE-DAILY
Always Dispense With a Medication Guide
Swallow tablet whole.
Do not chew, divide, or crush tablet.
100 Tablets Rx only
Veloxis PHARMACEUTICALS
PRINCIPAL DISPLAY PANEL — Envarsus 1 mg 30 Count Carton Label
NDC 68992-3010-3
Envarsus XR®
(tacrolimus
extended-release tablets)
1 mg
ONCE-DAILY
Swallow tablet whole.
Do not chew, divide,
or crush tablet.
Dosage: See Package Insert
for dosage information.
Always dispense with a Medication Guide
For oral use only
Veloxis PHARMACEUTICALS
30 Tablets
PRINCIPAL DISPLAY PANEL — Envarsus 1 mg 30 Count Bottle Label
NDC 68992-3010-3
Envarsus XR®
(tacrolimus extended-release tablets)
1 mg
ONCE-DAILY
Always Dispense With a Medication Guide
Swallow tablet whole.
Do not chew, divide, or crush tablet.
30 Tablets Rx only
Veloxis PHARMACEUTICALS
PRINCIPAL DISPLAY PANEL — Envarsus 1 mg 100 Count Carton Label
NDC 68992-3010-1
Envarsus XR®
(tacrolimus
extended-release tablets)
1 mg
ONCE-DAILY
Swallow tablet whole.
Do not chew, divide,
or crush tablet.
Dosage: See Package Insert
for dosage information.
Always dispense with a Medication Guide
For oral use only
Veloxis PHARMACEUTICALS
100 Tablets
PRINCIPAL DISPLAY PANEL — Envarsus 1 mg 100 Count Bottle Label
NDC 68992-3010-1
Envarsus XR®
(tacrolimus extended-release tablets)
1 mg
ONCE-DAILY
Always Dispense With a Medication Guide
Swallow tablet whole.
Do not chew, divide, or crush tablet.
100 Tablets Rx only
Veloxis PHARMACEUTICALS
PRINCIPAL DISPLAY PANEL — Envarsus 4 mg 30 Count Carton Label
NDC 68992-3040-3
Envarsus XR®
(tacrolimus
extended-release tablets)
4 mg
ONCE-DAILY
Swallow tablet whole.
Do not chew, divide,
or crush tablet.
Dosage: See Package Insert
for dosage information.
Always dispense with a Medication Guide
For oral use only
Veloxis PHARMACEUTICALS
30 Tablets
PRINCIPAL DISPLAY PANEL — Envarsus 4 mg 30 Count Bottle Label
NDC 68992-3040-3
Envarsus XR®
(tacrolimus extended-release tablets)
4 mg
ONCE-DAILY
Always Dispense With a Medication Guide
Swallow tablet whole.
Do not chew, divide, or crush tablet.
30 Tablets Rx only
Veloxis PHARMACEUTICALS
PRINCIPAL DISPLAY PANEL — Envarsus 4 mg 100 Count Carton Label
NDC 68992-3040-1
Envarsus XR®
(tacrolimus
extended-release tablets)
4 mg
ONCE-DAILY
Swallow tablet whole.
Do not chew, divide,
or crush tablet.
Dosage: See Package Insert
for dosage information.
Always dispense with a Medication Guide
For oral use only
Veloxis PHARMACEUTICALS
100 Tablets
PRINCIPAL DISPLAY PANEL — Envarsus 4 mg 100 Count Bottle Label
NDC 68992-3040-1
Envarsus XR®
(tacrolimus extended-release tablets)
4 mg
ONCE-DAILY
Always Dispense With a Medication Guide
Swallow tablet whole.
Do not chew, divide, or crush tablet.
100 Tablets
Veloxis PHARMACEUTICALS
ENVARSUS XR tacrolimus tablet, extended release | |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
|
ENVARSUS XR tacrolimus tablet, extended release | |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
|
ENVARSUS XR tacrolimus tablet, extended release | |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
|
Labeler — Veloxis Pharmaceuticals, Inc (028252150) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Veloxis Pharmaceuticals, Inc | 028252150 | MANUFACTURE (68992-3075), MANUFACTURE (68992-3010), MANUFACTURE (68992-3040) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Rottendorf Pharma GmbH | 315974691 | manufacture (68992-3075), manufacture (68992-3010), manufacture (68992-3040), analysis (68992-3075), analysis (68992-3010), analysis (68992-3040), label (68992-3075), label (68992-3010), label (68992-3040), pack (68992-3075), pack (68992-3010), pack (68992-3040) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Pharma Packaging Solutions, LLC dba Tjoapack, LLC | 928861723 | label (68992-3075), label (68992-3010), label (68992-3040), pack (68992-3075), pack (68992-3010), pack (68992-3040) |
Revised: 09/2023 Veloxis Pharmaceuticals, Inc
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.